» Articles » PMID: 8843306

Comparative Characterization of the Cephamycinase BlaCMY-1 Gene and Its Relationship with Other Beta-lactamase Genes

Overview
Specialty Pharmacology
Date 1996 Aug 1
PMID 8843306
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

A plasmidic beta-lactamase which hydrolyzed cephamycins was first detected and reported in 1989. At that time its description was restricted to phenotypic characteristics. We analyzed nucleotide sequence of its gene and explored it genetic relationship with other bla genes. The deduced amino acid sequence of the blaCMY-1 product was compared with those of other known plasmidic cephamycinases and of chromosomal AmpC beta-lactamases. The results indicate that the relationship of CMY-1 is closest to MOX-1 among the plasmidic cephamycinases and to AmpC of Pseudomonas aeruginosa among the chromosomal cephalosporinases. We conclude that the plasmidic cephamycinases described up to now may be classified into three families, as follows: CMY-1, MOX-1, and FOX-1 with AmpC of P. aeruginosa; CMY-2, BIL-1 and LAT-1 with AmpC of Citrobacter freundii; and MIR-1 with AmpC of Enterobacter cloacae. Plasmidic cephamycinases are now recognized as clinically relevant class C beta-lactamases.

Citing Articles

Insights into AMA205's Unprecedented Antibiotic Resistance.

Traglia G, Pasteran F, Moheb S, Akhtar U, Gonzalez S, Maldonado C Int J Mol Sci. 2024; 25(21).

PMID: 39518977 PMC: 11546953. DOI: 10.3390/ijms252111424.


Clinically Relevant β-Lactam Resistance Genes in Wastewater Treatment Plants.

Wasko I, Kozinska A, Kotlarska E, Baraniak A Int J Environ Res Public Health. 2022; 19(21).

PMID: 36360709 PMC: 9657204. DOI: 10.3390/ijerph192113829.


Class C β-Lactamases: Molecular Characteristics.

Philippon A, Arlet G, Labia R, Iorga B Clin Microbiol Rev. 2022; 35(3):e0015021.

PMID: 35435729 PMC: 9491196. DOI: 10.1128/cmr.00150-21.


Plasmid-Mediated AmpC β-Lactamase and Genes Among Gram-Negative Clinical Isolates.

Aryal S, Upreti M, Sah A, Ansari M, Nepal K, Dhungel B Infect Drug Resist. 2020; 13:4249-4261.

PMID: 33262619 PMC: 7699442. DOI: 10.2147/IDR.S284751.


Epidemiology of β-Lactamase-Producing Pathogens.

Bush K, Bradford P Clin Microbiol Rev. 2020; 33(2).

PMID: 32102899 PMC: 7048014. DOI: 10.1128/CMR.00047-19.


References
1.
Mathew A, Harris A, Marshall M, Ross G . The use of analytical isoelectric focusing for detection and identification of beta-lactamases. J Gen Microbiol. 1975; 88(1):169-78. DOI: 10.1099/00221287-88-1-169. View

2.
SANGER F, Nicklen S, Coulson A . DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977; 74(12):5463-7. PMC: 431765. DOI: 10.1073/pnas.74.12.5463. View

3.
Birnboim H, DOLY J . A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res. 1979; 7(6):1513-23. PMC: 342324. DOI: 10.1093/nar/7.6.1513. View

4.
Ambler R . The structure of beta-lactamases. Philos Trans R Soc Lond B Biol Sci. 1980; 289(1036):321-31. DOI: 10.1098/rstb.1980.0049. View

5.
Jaurin B, Grundstrom T . ampC cephalosporinase of Escherichia coli K-12 has a different evolutionary origin from that of beta-lactamases of the penicillinase type. Proc Natl Acad Sci U S A. 1981; 78(8):4897-901. PMC: 320287. DOI: 10.1073/pnas.78.8.4897. View